COMPOSÉ DE QUINAZOLINE

[Problem]Provided is a compound which is useful as an active ingredient of a pharmaceutical composition for treating lung cancer.[Means for Solution]The present inventors have studied a compound useful as an active ingredient of a pharmaceutical composition for treating lung cancer, and as a result,...

Full description

Saved in:
Bibliographic Details
Main Authors ABE, Tomoaki, KURAMOTO, Kazuyuki, AKAIWA, Michinori, YAMAKI, Susumu, KOIKE, Takanori, SATAKE, Yoshiki, NIGAWARA, Takahiro, SHIMADA, Itsuro, IMAIZUMI, Tomoyoshi, ARAKAWA, Keisuke, ARAKI, Takanobu, WATANABE, Kazushi, SHIMAZAKI, Masashi, KUNIKAWA, Shigeki
Format Patent
LanguageFrench
Published 11.12.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:[Problem]Provided is a compound which is useful as an active ingredient of a pharmaceutical composition for treating lung cancer.[Means for Solution]The present inventors have studied a compound useful as an active ingredient of a pharmaceutical composition for treating lung cancer, and as a result, it was found that a quinazoline compound has an excellent G12C mutation KRAS inhibitory activity, and which can be used as a therapeutic agent for lung cancer, and thereby the present invention has been completed. The quinazoline compound of the present invention and a salt thereof may be used as the therapeutic agent for lung cancer.
Bibliography:Application Number: MA20180047433